A detailed history of Boothbay Fund Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 56,784 shares of AZN stock, worth $3.66 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
56,784
Previous 31,800 78.57%
Holding current value
$3.66 Million
Previous $2.48 Million 78.39%
% of portfolio
0.12%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $4.35 Million - $4.98 Million
56,784 New
56,784 $4.42 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $5.84 Million - $6.66 Million
95,697 Added 301.17%
127,472 $8.64 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $1.97 Million - $2.2 Million
31,775 New
31,775 $2.14 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $2.51 Million - $2.72 Million
35,869 Added 110.34%
68,378 $4.89 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $2.05 Million - $2.33 Million
32,509 New
32,509 $2.26 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $1.54 Million - $3.95 Million
29,118 New
29,118 $1.6 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $3.52 Million - $4.16 Million
-65,155 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$55.56 - $60.79 $3.44 Million - $3.76 Million
-61,890 Reduced 48.72%
65,155 $3.91 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $3.76 Million - $4.67 Million
-77,642 Reduced 37.93%
127,045 $7.61 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $4.98 Million - $5.75 Million
105,617 Added 106.61%
204,687 $10.2 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $4.52 Million - $5.41 Million
93,178 Added 1581.43%
99,070 $4.95 Million
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $813,563 - $936,663
-15,330 Reduced 72.24%
5,892 $323,000
Q2 2020

Aug 14, 2020

SELL
$43.1 - $55.31 $543,749 - $697,790
-12,616 Reduced 37.28%
21,222 $1.12 Million
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $1.48 Million - $2.01 Million
-39,070 Reduced 53.59%
33,838 $1.51 Million
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $442,687 - $526,095
-10,426 Reduced 12.51%
72,908 $3.64 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $3.34 Million - $3.79 Million
83,334 New
83,334 $3.71 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.